Johanne Toutant

发表

The DNA Damage Response Pathway Regulates the Alternative Splicing of the Apoptotic Mediator Bcl-x*

L. Shkreta, L. Michelle, Johanne Toutant, 2010, The Journal of Biological Chemistry.

Protein Kinase C-Dependent Control of Bcl-x Alternative Splicing

L. Shkreta, Johanne Toutant, B. Chabot, 2007, Molecular and Cellular Biology.

Heterogeneous Nuclear Ribonucleoprotein K Represses the Production of Pro-apoptotic Bcl-xS Splice Isoform

Johanne Toutant, B. Chabot, T. Revil, 2009, The Journal of Biological Chemistry.

SRSF10 Connects DNA Damage to the Alternative Splicing of Transcripts Encoding Apoptosis, Cell-Cycle Control, and DNA Repair Factors

J. Manley, L. Shkreta, Johanne Toutant, 2016, Cell reports.

TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis

H. Soreq, M. Strong, L. Shkreta, 2018, Brain : a journal of neurology.

hnRNP A1 and hnRNP H can collaborate to modulate 5' splice site selection.

Jean-François Fisette, Johanne Toutant, B. Chabot, 2010, RNA.

A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells

M. Tyers, J. Coulombe-Huntington, L. Shkreta, 2021, NAR cancer.

The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation

M. Babu, W. Houry, L. Shkreta, 2021, Viruses.

Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replication

M. Blanchette, L. Shkreta, Johanne Toutant, 2016, Nucleic acids research.

Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes

Sherif Abou Elela, L. Shkreta, Johanne Toutant, 2008, Molecular Cancer Therapeutics.

hnRNP A1/A2 and Sam68 collaborate with SRSF10 to control the alternative splicing response to oxaliplatin-mediated DNA damage

L. Shkreta, Johanne Toutant, B. Chabot, 2018, Scientific Reports.

Splicing of Apoptotic Regulators Complex Also Control the Alternative Proteins Associated with the Exon Junction

Sherif Abou Elela, L. Shkreta, L. Michelle, 2012 .

Proteins Associated with the Exon Junction Complex Also Control the Alternative Splicing of Apoptotic Regulators

Sherif Abou Elela, H. Le Hir, L. Shkreta, 2011, Molecular and Cellular Biology.

Antagonistic Effects of the SRp30c Protein and Cryptic 5 ′ Splice Sites on the Alternative Splicing of the Apoptotic Regulator Bcl-x*

L. Shkreta, Johanne Toutant, B. Chabot, 2008, Journal of Biological Chemistry.

Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines.

Johanne Toutant, B. Chabot, E. Lapointe, 2003, Cancer research.

hnRNP I/PTB can antagonize the splicing repressor activity of SRp30c.

L. Shkreta, Johanne Toutant, B. Chabot, 2007, RNA.

RBFOX 1 Cooperates with MBNL 1 to Control Splicing in Muscle , Including Events Altered in Myotonic Dystrophy Type 1

G. Meola, J. Puymirat, Johanne Toutant, 2018 .

RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1

G. Meola, J. Puymirat, Johanne Toutant, 2014, PloS one.

Transiently depleting RNPS1 leads to perdurable changes in alternative splicing

Johanne Toutant, B. Chabot, E. Lapointe, 2018, bioRxiv.

Regulatory interplay between SR proteins governs CLK1 kinase splice variants production

L. Shkreta, Johanne Toutant, Benoit Chabot, 2024, RNA.

The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response

J. Coulombe-Huntington, L. Shkreta, Johanne Toutant, 2024, Oncotarget.